MSB 2.42% $1.41 mesoblast limited

Ann: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs

  1. lightbulb Created with Sketch. 851
    • Release Date: 24/06/19 09:55
    • Summary: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs
    • Price Sensitive: Yes
    • Download Document  134.93KB
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.41
Change
-0.035(2.42%)
Mkt cap ! $703.1M
Open High Low Value Volume
$1.44 $1.44 $1.39 $347.6K 245.9K

Buyers (Bids)

No. Vol. Price($)
1 1066 $1.41
 

Sellers (Offers)

Price($) Vol. No.
$1.43 1139 1
View Market Depth
Last update - 16.10pm 23/08/2019 (20 minute delay) ?
(live)
Last
$1.42
  Change
-0.035 ( 0.90 %)
Open High Low Volume
$1.44 $1.44 $1.39 8083
Last updated 15.59pm 23/08/2019 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.